Steroids in Septic Shock: Evidence-Based Approach

Direct Answer

Administer hydrocortisone 200 mg/day intravenously only to septic shock patients who remain hypotensive despite adequate fluid resuscitation (≥30 mL/kg crystalloid) and moderate-to-high dose vasopressors (typically norepinephrine >0.1-0.2 mcg/kg/min). 1, 2 This represents a conditional recommendation based on consistent guideline consensus, with steroids acting as a "savior" in the narrow context of vasopressor-refractory shock while remaining a potential "villain" when used indiscriminately.

When to Use Steroids: The Critical Decision Point

Mandatory Prerequisites Before Considering Steroids

Complete adequate fluid resuscitation first: Administer at least 30 mL/kg crystalloid within the first 3 hours before or concurrent with vasopressor initiation. 1, 2
Optimize vasopressor therapy: Initiate norepinephrine as first-line agent targeting MAP ≥65 mmHg, and escalate to moderate-to-high doses (generally >0.1-0.2 mcg/kg/min) before adding steroids. 1, 2
Add second-line vasopressor if needed: Consider adding vasopressin 0.03 units/minute to norepinephrine before initiating steroids. 1

The Specific Indication

Hydrocortisone is indicated only when hemodynamic stability cannot be achieved despite the above measures—this defines "vasopressor-unresponsive septic shock." 3, 1 The 2012 Surviving Sepsis Campaign guidelines explicitly state this threshold: patients whose blood pressure remains unresponsive to vasopressor therapy for more than 60 minutes despite adequate fluid resuscitation. 3

The Evidence: Why This Narrow Indication Matters

Mortality Benefit Is Context-Dependent

The landmark French trial by Annane et al. (2002) demonstrated a significant mortality reduction (63% vs 53%, hazard ratio 0.67, P=0.02) in patients with vasopressor-unresponsive septic shock and relative adrenal insufficiency. 4 However, the subsequent CORTICUS trial, which enrolled patients regardless of vasopressor responsiveness, showed no mortality benefit. 3 This divergence reveals the critical point: steroids help only the sickest patients with truly refractory shock.

The baseline mortality rates tell the story: 61% in the French trial versus 31% in CORTICUS. 3 Patients who respond adequately to fluids and vasopressors do not benefit from steroids and should not receive them. 3, 1

Consistent Benefits Across All Studies

Faster shock reversal: Steroids consistently accelerate vasopressor withdrawal (hazard ratio 1.91, P=0.001 in the French trial). 4, 5
Reduced vasopressor requirements: All major trials demonstrate decreased need for vasopressor support. 6, 5
No increased superinfection risk at physiologic doses: Multiple meta-analyses confirm that low-dose hydrocortisone (200 mg/day) does not increase infection rates, though high-dose regimens do cause harm. 6, 5

Dosing Regimen: The Practical Protocol

Standard Dose

Hydrocortisone 200 mg per day, administered as continuous infusion (preferred) or divided doses (50 mg IV every 6 hours). 1, 2 The continuous infusion is preferred based on guideline recommendations, though clinical outcomes appear similar. 2, 7

Fludrocortisone: Not Recommended

Do not add fludrocortisone to hydrocortisone. 1, 8 While the original French trial used both agents, 4 a 2024 propensity-weighted analysis found no difference in shock-free days, duration of shock, or mortality when fludrocortisone was added to hydrocortisone. 8 Current guidelines recommend hydrocortisone alone. 1

Duration and Tapering

Continue full-dose hydrocortisone for at least 3 days before considering dose reduction. 2
Begin tapering only when vasopressors are no longer required, not before. 1, 2
Taper gradually over 6-14 days rather than stopping abruptly to avoid rebound inflammation and hemodynamic deterioration. 1, 2
Never use a fixed duration approach; taper based on clinical response and vasopressor requirements. 2

What NOT to Do: Critical Pitfalls

Do Not Use the ACTH Stimulation Test

The ACTH stimulation test should not be used to identify patients who should receive hydrocortisone. 1, 2 The CORTICUS trial demonstrated that ACTH test results (responders vs. nonresponders) did not predict faster shock resolution or mortality benefit. 3 This represents a major shift from earlier practice based on the French trial. 4

Do Not Use Steroids in Sepsis Without Shock

Hydrocortisone should not be administered in patients with sepsis who do not have septic shock. 1, 2 The indication is specifically for shock, not sepsis alone.

Avoid Etomidate for Intubation

Do not use etomidate for intubation in patients who may require hydrocortisone, as it suppresses the hypothalamic-pituitary-adrenal axis and worsens outcomes. 1, 2

Do Not Use High Doses

Avoid hydrocortisone doses >400 mg per day, as higher doses provide no additional benefit and may increase harm. 2 High-dose corticosteroid therapy is associated with increased adverse events. 6

Do Not Stop Abruptly

Never stop hydrocortisone abruptly, as this causes hemodynamic and immunologic rebound. 2

Monitoring During Treatment

Essential Parameters

Serum sodium: Monitor for hypernatremia, especially if treatment extends beyond 48-72 hours. 2
Blood glucose: Assess for hyperglycemia, which occurs frequently with steroid therapy. 2, 5
Superinfection surveillance: Watch for new infections, though risk is not substantially increased at physiologic doses. 2, 6
Clinical response: Reassess after 2-3 days to determine if therapy should continue. 2

The Nuanced Reality: When Steroids Are "Savior"

Steroids function as a "savior" specifically in patients with:

High vasopressor requirements (norepinephrine >0.1-0.2 mcg/kg/min despite adequate fluids). 2, 5
Evidence of multiorgan failure and escalating organ dysfunction. 5
Primary lung infections as the sepsis source. 5

In these patients, hydrocortisone consistently accelerates shock reversal, reduces vasopressor duration, and may shorten mechanical ventilation. 4, 5 The mortality benefit appears greatest in this subset. 5

The Nuanced Reality: When Steroids Are "Villain"

Steroids become a "villain" when:

Used indiscriminately in all septic patients without shock. 1, 2
Administered at high doses (>400 mg/day), which increases harm without benefit. 2, 6
Given to patients who respond adequately to fluids and vasopressors, where no benefit exists. 3, 1
Stopped abruptly, causing rebound inflammation and hemodynamic collapse. 1, 2

Practical Algorithm for Decision-Making

Confirm septic shock diagnosis (sepsis + hypotension requiring vasopressors to maintain MAP ≥65 mmHg after adequate fluid resuscitation). 1
Administer ≥30 mL/kg crystalloid within first 3 hours. 1, 2
Initiate norepinephrine as first-line vasopressor, targeting MAP ≥65 mmHg. 1
Escalate norepinephrine to moderate-to-high doses (>0.1-0.2 mcg/kg/min). 2
Consider adding vasopressin 0.03 units/minute if MAP target not achieved. 1
If hypotension persists despite steps 1-5 for >60 minutes: Start hydrocortisone 200 mg/day IV (continuous infusion preferred or 50 mg IV every 6 hours). 3, 1, 2
Continue full dose for ≥3 days, then taper gradually over 6-14 days when vasopressors are discontinued. 1, 2

The Bottom Line for Clinical Practice

Steroids are neither universal savior nor villain—they are a targeted therapy for the specific subset of septic shock patients with vasopressor-refractory hypotension. 3, 1 The key is patient selection: use hydrocortisone 200 mg/day only after optimizing fluids and vasopressors, continue for at least 3 days, and taper gradually when vasopressors are weaned. 1, 2 Do not use the ACTH test, do not add fludrocortisone, and do not use steroids in sepsis without shock. 1, 2

In septic shock patients who remain hypotensive despite adequate fluid resuscitation and high‑dose vasopressors, when is low‑dose hydrocortisone (± fludrocortisone) indicated and what dosing regimen should be used?

Help us tailor your experience